GlassScriptPhysician profile
Daniel Daehyun Kim
NPI 1629575147
$18,440.86
in general payments reported to CMS, 2019-2025
21 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $517 · 2023: $2,146 · 2024: $5,594 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Food and Beverage: $2,627 · Travel and Lodging: $625 · Education: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $14,063.30 |
| Food and Beverage | $2,627.25 |
| Travel and Lodging | $624.81 |
| Education | $608.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,147.31 | 2024-2025 | General - Atherectomy, Avvigo Guidance System, Watchman |
| Medtronic, INC. | $3,164.28 | 2023-2024 | Onyx Frontier |
| Abiomed | $1,023.98 | 2023-2024 | Impella |
| Amgen INC. | $473.52 | 2022-2023 | Repatha |
| Abbott Laboratories | $431.60 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite Precision |
| Irhythm Technologies, INC. | $299.10 | 2024 | Zio Monitor, Zio Xt Patch |
| Acist Medical Systems, INC. | $253.15 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $245.99 | 2022-2023 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $241.84 | 2024 | Uptravi, Opsumit |
| Edwards Lifesciences Corporation | $215.55 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque |
| Inari Medical, INC. | $154.27 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $138.86 | 2022 | |
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Pfizer INC. | $120.03 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $114.75 | 2023 | Amvuttra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.57 | 2023-2024 | Lifevest |
| Heartflow, INC. | $90.44 | 2023 | Ffrct |
| Terumo Medical Corporation | $41.37 | 2023 | Metacross Otw, Heartrail, Glidesheath Slender |
| Opko Pharmaceuticals, LLC | $19.86 | 2023 | Rayaldee |
| Takeda Pharmaceuticals U.S.A., INC. | $14.47 | 2022 | |
| Getinge USA Sales, LLC | $13.37 | 2023 | Cardiosave Hybrid, Type B Plug |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.